SUBSCRIBE
SUBSCRIBE
News   Business

Alnylam Pharmaceuticals Reports Third Quarter 2009 Financial Results

November 5, 2009 | 
1 min read
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, today reported its consolidated financial results for the third quarter ended September 30, 2009 and company highlights.
Earnings
Alnylam Pharmaceuticals
MORE ON THIS TOPIC
Words IPO (Initial public offering) with the trading data on the background.
IPO
2026 IPO stock tracker: How newly public biotechs are performing
September 9, 2026
 · 
1 min read
 · 
Gabrielle Masson
Abstract retro vintage landscape with mountains and sun. Summer wavy aesthetic bakground in warm retro colors. Modern flat vector illustration with copy space for text
Venture capital
Solstice rises with $225M to develop next-gen CTLA-4 drug from China
September 9, 2026
 · 
2 min read
 · 
Annalee Armstrong
Innovation - Think differently - Being different, taking risky, move for success in life -The graphic of rocket also represents the concept of courage, enterprise, confidence, belief, fearless, daring,
Funding
Caspian launches with $50M, Lilly support to advance disease-modifying diabetes bet
September 9, 2026
 · 
2 min read
 · 
Tristan Manalac
Heart attack and heart disease, ecg background. 3d illustration
cardiovascular disease
Novo shutters 2 more heart disease studies, indicating IL-6 is ‘invalid target’
September 8, 2026
 · 
2 min read
 · 
Gabrielle Masson